Investment Summary

Exits ProStrakan Group

On September 10, 2009, invested in life science company ProStrakan Group from Warburg Pincus for 300M GBP

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is largest (disclosed) transaction.
  • This is transaction in the United Kingdom.

Investment Summary

Date 2009-09-10
Target ProStrakan Group
Sector Life Science
Sellers(s) Warburg Pincus
Deal Type Stake Sale
Deal Value 300M GBP

Target

ProStrakan Group

Galashiels, United Kingdom
website
ProStrakan Group plc was created in 2004 by the merger of Strakan Group plc and ProSkelia. The combined company, based in Galashiels, Scotland, is a rapidly growing international specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets

Search 177,729 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1966
PE ASSETS 89.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.


DEAL STATS #
Overall 46 of 209
Sector (Life Science) 8 of 18
Type (Stake Sale) 2 of 8
Country (United Kingdom) 7 of 16
Year (2009) 3 of 6
Size (of disclosed) 33 of 55
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-28 Kontron AG

Augsburg, Germany

Kontron AG is a manufacturer of embedded computer technology (ECT) and supplier of OEMs, system integrators and application providers in a broad range of market segments, including data and telecommunications, automation, mobile computing, medical technology, military technology, aerospace, and measuring and control engineering.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-25 easycash

Ratingen, Germany

easycash is the German point of sale (POS) Network Service Provider. easycash offers customised card-based payment solutions and credit card routing to a broad range of merchant customers.

Sell €290M